KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 3 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,428 | +170.4% | 44,928 | +265.9% | 0.00% | – |
Q2 2023 | $22,348 | -52.3% | 12,279 | 0.0% | 0.00% | – |
Q1 2023 | $46,844 | -68.6% | 12,279 | -13.8% | 0.00% | – |
Q1 2021 | $149,000 | -54.8% | 14,239 | -33.8% | 0.00% | – |
Q4 2020 | $330,000 | +16.6% | 21,525 | +12.1% | 0.00% | – |
Q3 2020 | $283,000 | -20.1% | 19,198 | +2.7% | 0.00% | -100.0% |
Q2 2020 | $354,000 | +40.5% | 18,688 | +39.5% | 0.00% | 0.0% |
Q1 2020 | $252,000 | – | 13,397 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |